Elkhorn Partners Limited Partnership »

Crispr Therapeutics shares owned by Elkhorn Partners Limited Partnership

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Elkhorn Partners Limited Partnership from 13F filings

Historical chart of Elkhorn Partners Limited Partnership investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Elkhorn Partners Limited Partnership consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Elkhorn Partners Limited Partnership

Quarter filed Position value Share count Share price at filing
2023-09-30 $11k 250 44.00
2023-06-30 $2.0k 30 66.67
2023-03-31 $27k 600 45.00
2022-12-31 $55k 1.4k 40.74
2022-03-31 $35k 550 63.64
2021-12-31 $27k 350 77.14
2021-09-30 $14k 125 112.00
2021-06-30 $20k 125 160.00